VSTM - Verastem Oncology drops despite Q3 double beat
2025-11-04 12:12:01 ET
More on Verastem
- Verastem, Inc. (VSTM) Q3 2025 Earnings Call Transcript
- Verastem, Inc. 2025 Q3 - Results - Earnings Call Presentation
- Verastem: Navigating Critical Steps In Commercialization And Development (Downgrade)
- Verastem signals confidence in AVMAPKI FAKZYNJA CO-PACK growth and prepares for pivotal 2026 clinical milestones
- Verastem Q3 2025 Earnings Preview